glp 1 agonist vs metformin Synergistic effects of with liraglutide against endothelial dysfunction through GLP-1 receptor and PKA signalling pathway The dual impact of GLP-1

They also offer the

As online weight-loss clinics boom, reports of GLP-1 overdoses, dosing mistakes, and hospitalizations are climbing.

Guidelines have evolved considerably from routine medication cessation in 2023 to GLP-1 RA continuation with individualised risk assessment in 20242025, illustrating increasing acknowledgment that certain theoretical risks may be underestimated

has details on the plan to remove auto-injectors in order to allow greater access to patients at lower prices.

The FDA just warned Novo Nordisk over unreported GLP-1 side effects

Glucagon-like peptide-1 (GLP-1) is an incretin hormone released from gut enteroendocrine cells that modulates glucose metabolism by controlling insulin excretion and glucagon secretion and inhibits gastric emptying leading to decreased food intake, thus limiting weight gain